SLR Healthcare ABL provided a $5 million asset-based revolving credit facility for a global medical device company focused on treating cervical and lumbar spinal disease. The company’s product line is backed by over 30 years of clinical success and is sold through distributors in the U.S. and internationally. The SLR credit facility will provide working capital support as the company executes its strategic plan.
In conjunction with the asset-based revolving credit facility, the SLR platform, through its life science finance team, also provided a $60 million first lien term loan to the company.
